FDA Adverse Event Malfunction Summary report: N

ACCESS® 2 IMMUNOASSAY SYSTEM

MDR report key: 2320955 · Received November 3, 2011

Report

Report Number
2122870-2011-05170
Event Type
Malfunction
Date Received
November 3, 2011
Date of Event
September 26, 2011
Report Date
October 5, 2011
Manufacturer
BECKMAN COULTER INC.
Product Code
DHA
PMA / PMN Number
K980173
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER INC (BEC) IN REGARDS TO A DISCREPANT RESULT FOR BHCG ON ONE PATIENT'S SAMPLE, WHICH WAS GENERATED BY THE UNICEL DXI 800 ACCESS IMMUNOASSAY ANALYZER. THE DISCREPANT RESULT WAS NOT REPORTED OUT OF THE LABORATORY. DILUTION TESTING WAS PERFORMED AND RECOVERED NON-LINEARLY. SERVICE WAS NOT DISPATCHED FOR THIS EVENT. THE CUSTOMER DID NOT RECEIVE NOTICE OF DEATH OR INJURY TO PATIENT REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT. PATIENT SAMPLE INFORMATION, QC DATA, OR SYSTEM CHECK DATA WERE NOT PROVIDED BY THE CUSTOMER. THE SAMPLE WAS SENT TO CUSTOMER PRODUCT LINE SUPPORT (CPLS) EAST FOR ADDITIONAL PENDING. CPLS CONCLUSION: CPLS REPEATED CUSTOMER'S RESULT ON NEAT SAMPLE. DILUTION TEST RESULTS ALLOWED TO DETECT INTERFERENCE SINCE THE TEST WAS NOT LINEAR. HETEROPHILE TESTING TENDED TO SHOW THE PRESENCE OF INTERFERING SUBSTANCES SINCE AT LEAST ONE OF THE HETEROPHILE BLOCKERS USED IN THE TEST SLIGHTLY LOWERED THE SIGNAL. THE CHROMATOGRAPHIC ANALYSIS SHOWED THAT ELUTION FRACTIONS CORRESPONDING TO MOLECULE (43 KDA) WERE TESTED ON THE ACCESS ASSAY AND WERE NOT FOUND REACTIVE FOR THCG CONFIRMING THE VERY LOW LEVEL OF THCG IN THIS SAMPLE. SAMPLE SENT FOR ALTERNATIVE TESTING (ROCHE) WAS FOUND NEGATIVE CONFIRMING OUR RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® 2 IMMUNOASSAY SYSTEM ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE DHA BECKMAN COULTER INC. TOTAL BHCG REAGENT PACK 170067

Patients

Seq Age Sex Outcome Treatment
1 33 YR